AU2001277733A1 - Chimeric human-type vascular endothelial cell growth factor - Google Patents

Chimeric human-type vascular endothelial cell growth factor

Info

Publication number
AU2001277733A1
AU2001277733A1 AU2001277733A AU7773301A AU2001277733A1 AU 2001277733 A1 AU2001277733 A1 AU 2001277733A1 AU 2001277733 A AU2001277733 A AU 2001277733A AU 7773301 A AU7773301 A AU 7773301A AU 2001277733 A1 AU2001277733 A1 AU 2001277733A1
Authority
AU
Australia
Prior art keywords
growth factor
cell growth
vascular endothelial
endothelial cell
chimeric human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277733A
Inventor
Masabumi Shibuya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Todai TLO Ltd
Original Assignee
Ct For Advanced Science & Tech
Center for Advanced Science and Technology Incubation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct For Advanced Science & Tech, Center for Advanced Science and Technology Incubation Ltd filed Critical Ct For Advanced Science & Tech
Publication of AU2001277733A1 publication Critical patent/AU2001277733A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001277733A 2000-08-10 2001-08-09 Chimeric human-type vascular endothelial cell growth factor Abandoned AU2001277733A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-242629 2000-08-10
JP2000242629 2000-08-10
PCT/JP2001/006856 WO2002014367A1 (en) 2000-08-10 2001-08-09 Chimeric human-type vascular endothelial cell growth factor

Publications (1)

Publication Number Publication Date
AU2001277733A1 true AU2001277733A1 (en) 2002-02-25

Family

ID=18733629

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277733A Abandoned AU2001277733A1 (en) 2000-08-10 2001-08-09 Chimeric human-type vascular endothelial cell growth factor

Country Status (4)

Country Link
US (3) US7405278B2 (en)
EP (1) EP1323736A4 (en)
AU (1) AU2001277733A1 (en)
WO (1) WO2002014367A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1323736A4 (en) * 2000-08-10 2005-08-24 Masabumi Shibuya Chimeric human-type vascular endothelial cell growth factor
WO2010083495A2 (en) * 2009-01-18 2010-07-22 The Board Of Trustees Of The Leland Stanford Junior University Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha v beta 3 integrin
US11210554B2 (en) 2019-03-21 2021-12-28 Illumina, Inc. Artificial intelligence-based generation of sequencing metadata

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064331C (en) 1991-03-28 2003-02-18 Marvin L. Bayne Vascular endothelial cell growth factor c subunit
NZ514872A (en) * 1997-04-25 2005-01-28 Collateral Therapeutics Truncated VEGF-B, VRF-2, VEGF-C, PlGF, VEGF-3, poxvirus ORF-1 and poxvirus ORF-2 proteins
DE60131146T2 (en) * 2000-02-25 2008-03-06 Ludwig Institute For Cancer Research MATERIALS AND METHODS CONTAINING HYBRID VASCULAR ENDOTHELIC GROWTH FACTORS DNA AND PROTEINS AND SCREENING METHOD FOR MODULATORS
EP1323736A4 (en) * 2000-08-10 2005-08-24 Masabumi Shibuya Chimeric human-type vascular endothelial cell growth factor

Also Published As

Publication number Publication date
US20080319174A1 (en) 2008-12-25
EP1323736A4 (en) 2005-08-24
EP1323736A1 (en) 2003-07-02
US20080319178A1 (en) 2008-12-25
US20040038341A1 (en) 2004-02-26
US7405278B2 (en) 2008-07-29
WO2002014367A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
AU2002252631A1 (en) Vascular endothelial growth factor 2
WO2002083850A8 (en) Vascular endothelial growth factor 2
EP1313512A4 (en) Vascular endothelial growth factor 2
AUPR030900A0 (en) Growth factor complex
AU2001228742A1 (en) Ligand for vascular endothelial growth factor receptor
AU2583399A (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
EP1029519A3 (en) Sacro-iliac implant
AU2002211695A1 (en) Methods to assess vascular endothelial function
AU2001296618A1 (en) Container holding assembly
AU2001251485A1 (en) Container
AU2001296869A1 (en) Container
AU2001267516A1 (en) Container
AU5023300A (en) Vascular endothelial growth factor variants
EP1062319A4 (en) Vascular endothelial growth factor 2
EP1130098A3 (en) Mammalian osteoregulins
AU5439998A (en) Vascular endothelial growth factor
AU2002363322A8 (en) Endothelial cell derived hemotopoietic growth factor
AU2001231088A1 (en) Mutli-purpose container
AU4555499A (en) Improved specimen container
AU2001269441A1 (en) Container
AU2001238138A1 (en) Body-cooling container
AU5026100A (en) Vascular endothelial growth factor dimers
AU2002313770A1 (en) Vascular endothelial growth factor 2
AU2001277733A1 (en) Chimeric human-type vascular endothelial cell growth factor
AU6983000A (en) Chimeric proteins